🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

26 recruiting trials

for Gastroesophageal Cancer (GC)

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) NCT05733689Phase 11 site📍 Orange University of California, Irvine · Tests: FLOT, FOLFOX, FOLFIRI, FOLFIRINOX, PACLITAXEL with or without CARBOPLATIN A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. NCT06773312Phase 11 site📍 Beijing Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. · Tests: BC001+Sintilimab+XELOX A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites📍 Phoenix📍 Scottsdale📍 Duarte Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC NCT06023758Phase 21 site📍 Beijing Peking University · Tests: KN026, KN046, XELOX Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer NCT07635836NA1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Double-tract reconstruction A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma NCT07069712Phase 270 sites📍 Newark📍 Washington D.C.📍 Fairway AstraZeneca · Tests: Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd), Capecitabine, 5-Fluorouracil (5-FU) SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure NCT07311408Phase 21 site📍 Shenyang Jingdong Zhang · Tests: SHR-1701+Rivoceranib + SHR-2554, SHR-1701 + Rivoceranib Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer NCT06687291n/a1 site📍 Huddinge Karolinska Institutet Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC NCT04342910Phase 31 site📍 Beijing Jiangsu HengRui Medicine Co., Ltd. · Tests: camrelizumab, Apatinib Mesylate, Paclitaxel, Irinotecan Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. NCT07217704Phase 319 sites📍 Cerritos📍 Duarte📍 Irvine SOFIE · Tests: [18F]FAPI-74 PET/CT Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens NCT06572319Phase 1, Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Disitamab Vedotin(RC48) Plus Tratuzumab Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer NCT07689851Phase 23 sites📍 Shenzhen📍 Taiyuan📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: COPOX, Radiotherapy, SHR-1701 Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients NCT06650332Phase 1, Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: cadonilimab, Trastuzumab, XELOX, Disitamab Vedotin, mFOLFOX6 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites📍 Phoenix📍 San Francisco📍 Hartford BioNTech SE · Tests: BNT326, Pumitamig, Itraconazole, Paroxetine A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) NCT06506292Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Adebrelimab, XELOX A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172Phase 110 sites📍 Beverly Hills📍 Santa Monica📍 Houston Epkin · Tests: OKN4395, Pembrolizumab, Fasting, Fed, H2 Receptor Antagonist Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808Phase 1, Phase 23 sites📍 Duarte📍 Santa Monica📍 Fairfax BigHat Biosciences, Inc. · Tests: BHB810 Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer NCT07315854Phase 21 site📍 Beijing Beijing Friendship Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), SOX Chemotherapy A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors NCT07801508Phase 12 sites📍 Darlinghurst📍 Kyoto Novartis Pharmaceuticals · Tests: [68Ga]Ga-DWJ155 A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment NCT07518147Phase 31 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M05D1, Paclitaxel, Docetaxel, Irinotecan hydrochloride BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer NCT07629609Phase 21 site📍 Copenhagen Barbara Malene Fischer · Tests: [68Ga]Ga-FAPI-46 XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC NCT06742411Phase 1, Phase 22 sites📍 Chengdu📍 Chengdu West China Hospital · Tests: XELOX+Sintilimab+HBOT Validating a Medical AI Fine-Tuning Platform for Major Diseases NCT07795645n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: Smart Medical Big Data Dataset Construction, Large-Scale Medical Knowledge Graph Construction, Multi-Disease Medical La… LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma NCT07362186Phase 31 site📍 Beijing LaNova Medicines Limited · Tests: LM-108 in combination with Toripalimab, Paclitaxel injection intravenous infusion A Phase 1 Study of the Safety and Tolerability of CTX-10726 NCT07419841Phase 18 sites📍 Phoenix📍 Jacksonville📍 Rochester Compass Therapeutics · Tests: CTX-10726
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy